AI-Empowered MR-guided Radiotherapy for the Treatment of Cancer

Tech ID: T-021391

Published date: 9/12/2025

Value Proposition: Innovative real-time prediction method that uses deep learning to track tumors.

Technology Description

Researchers at Washington University in St. Louis have developed a pioneering method that leverages prior 3D cine MRI and simulation CT scans to predict dynamic 3D MRIs from X-ray projections using a patient-specific deep learning network. Conventional radiotherapy methods often lack precision, particularly at high doses and in complex anatomical sites, due to dynamic variations in patient anatomy during treatment. While MR-guided radiotherapy (MRgRT) offers improved accuracy through adaptive planning and real-time imaging, it is extremely complex, and its resource requirements limit its use in community hospitals.

This patient-specific deep learning network provides a scalable and accessible solution for community clinics to utilize MRgRT with conventional linear accelerators (LINACs), without having to use MR-guided radiotherapy, which enhances accessibility and adaptability, ensuring precise and personalized radiotherapy care, thereby improving the precision and effectiveness of cancer treatment for a wider range of patients.

Stage of Research

Tested in clinical setting

Applications

  • Cancer treatment

Key Advantages

  • Tracks tumors in real-time facilitating organ-at-risk management

  • Can be integrated with conventional LINACs, enhancing accessibility and adaptability

  • Makes advanced MR-guided techniques available to community hospitals

Patents

Patent application filed

Related Web Links – Kim Taeho Profile

Categories

Inventors

Contact

Weilbaecher, Craig
314-747-0685
cweilbaecher@wustl.edu

Create a Collection
Creating...